Innovative Therapeutics Gabaeron specializes in developing advanced therapies for neurological diseases by integrating precision medicine, regenerative medicine, and pharmacological interventions, indicating a need for specialized biotech products and services in these areas.

Growing Financial Base With revenues between 1 million and 10 million dollars and securing 3 million dollars in funding, Gabaeron presents opportunities for partnership in research collaborations, clinical trial support, and technology licensing.

Research Focus As a biotech company focused on stem cell and small molecule therapies targeting vulnerable brain cell populations, Gabaeron may require advanced lab equipment, cell culture technologies, and bioprocessing solutions.

Talent Acquisition Currently hiring and with a small team of 11 to 50 employees, Gabaeron is likely seeking innovative tools for recruitment, employee engagement, and specialized scientific staffing services to support its growth.

Market Expansion Operating in a niche but rapidly evolving field of neurological regenerative therapies, Gabaeron offers business development opportunities in expanding into new markets, securing additional funding, and forming strategic partnerships with other biotech leaders.